Schenk G, Albrecht H P, Lietz H
Arzneimittelforschung. 1978;28(3a):518-9.
Labelling of 14-hydroxy-3beta-[4-O-methyl-alpha-L-rhamnopyranosyl)oxy]-14beta-bufa-4,20,22-trienolide (meproscillarin, Clift) by introduction of dueterium and tritium at the metabolically stable C-19 position is described.
描述了通过在代谢稳定的C-19位置引入氘和氚对14-羟基-3β-[4-O-甲基-α-L-鼠李吡喃糖基)氧基]-14β-蟾蜍-4,20,22-三烯内酯(美普罗西拉林,克利夫特)进行标记的方法。